Back

Verigicuat: standard therapy for HFrEF?

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Controversies in contemporary drug therapy for heart failure Cardiovascular Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

3 More presentations in this session

Presentation thumbnail
Digitoxin and digoxin: standard therapy for HFrEF?
Professor U. Bavendiek (Hannover, DE)
Slides Video
Presentation thumbnail
Non-steroidal mineralocorticoid receptor antagonists (MRAs): standard therapy for HFpEF?
Doctor A. Ruwald (Copenhagen, DK)
Slides Video
Presentation thumbnail
Controversies in contemporary drug therapy for heart failure - discussion
Video

Access the full session

Session thumbnail
Controversies in contemporary drug therapy for heart failure
Video

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Presentation
VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure
thumbnail
Congress Presentation
Vericiguat
thumbnail
Congress Presentation
Advancing therapeutic options in HFrEF: the VICTOR trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources